La Jolla, CA, United States of America

Roberto Tinoco

This inventor holds 3 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Sanford Burnham Prebys Medical Discovery Institute, Technion Research & Development Foundation Ltd. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roberto Tinoco. Retrieved from https://idiyas.com/inventor/roberto-tinoco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Roberto Tinoco

Introduction

Roberto Tinoco is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of cancer treatment through his innovative research and patents. With a total of 3 patents, Tinoco's work focuses on the relationship between gut microbiota and cancer.

Latest Patents

Tinoco's latest patents include groundbreaking methods for treating cancer by regulating gut microbiota. One of his notable inventions involves the ubiquitin ligase, RNF5, which plays a crucial role in gut microbiota composition and influences the immune checkpoint response to tumors. His research indicates that RNF5 deficient animals show significant inhibition of tumor development, alongside an altered gut microbiota composition. The patents disclose methods of treating cancer by administering selected bacterial species and/or prebiotics that promote the growth of these bacterial species. Additionally, he explores the combination of these treatments with anti-cancer agents to enhance therapeutic efficacy.

Career Highlights

Throughout his career, Tinoco has worked with esteemed organizations such as the Technion Research & Development Foundation Limited and the Sanford Burnham Prebys Medical Discovery Institute. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Tinoco has collaborated with notable colleagues, including Yan Li and Scott Peterson. These partnerships have further enriched his research endeavors and have led to significant advancements in understanding cancer treatment.

Conclusion

Roberto Tinoco's innovative work in the field of cancer treatment through gut microbiota regulation showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving therapeutic strategies for cancer patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…